Profile change history

What changed for Trofinetide?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed Trofinetide identity.

27Total events
27Record additions
0Version changes
5Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 27 connected records →

Showing the latest 27 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 15, 2026.

Record added

ClinicalTrials.gov record NCT02715115

PeptideScanner retained ClinicalTrials.gov record NCT02715115 at 2026-11-15T21:57:22.404Z. Its registry update date was 2020-08-14, and PeptideScanner's reviewed identity mapping was trofinetide.

PeptideScanner change date
November 15, 2026
Cited source date
August 14, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04181723

PeptideScanner retained ClinicalTrials.gov record NCT04181723 at 2026-11-15T21:57:22.404Z. Its registry update date was 2024-04-08, and PeptideScanner's reviewed identity mapping was trofinetide.

PeptideScanner change date
November 15, 2026
Cited source date
April 8, 2024
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT04279314

PeptideScanner retained ClinicalTrials.gov record NCT04279314 at 2026-11-15T21:57:22.404Z. Its registry update date was 2024-04-11, and PeptideScanner's reviewed identity mapping was trofinetide.

PeptideScanner change date
November 15, 2026
Cited source date
April 11, 2024
Evidence lane
Clinical trials
Record added

Federal Register notice 2023-06593

The Federal Register published notice 2023-06593, attributed to FDA and its parent HHS department, on 2023-03-30. Its official title is “Issuance of Priority Review Voucher; Rare Pediatric Disease Product,” and PeptideScanner's exact reviewed identity mapping connects the document to Trofinetide.

PeptideScanner change date
November 15, 2026
Cited source date
March 30, 2023
Evidence lane
Regulatory
Record added

Federal Register notice 2024-21941

The Federal Register published notice 2024-21941, attributed to FDA and its parent HHS department, on 2024-09-25. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; DAYBUE,” and PeptideScanner's exact reviewed identity mapping connects the document to Trofinetide.

PeptideScanner change date
November 15, 2026
Cited source date
September 25, 2024
Evidence lane
Regulatory
Record added

Trofinetide.

PubMed lists PMID 37279541 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2023-07-21 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 24, 2023
Evidence lane
Literature metadata
Record added

Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study.

PubMed lists PMID 37291210 in Nature medicine as Clinical Trial, Phase III, Randomized Controlled Trial, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-06-08 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 1, 2025
Evidence lane
Literature metadata
Record added

Trofinetide: a pioneering treatment for Rett syndrome.

PubMed lists PMID 37460385 in Trends in pharmacological sciences as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-07-16 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 3, 2024
Evidence lane
Literature metadata
Record added

Trofinetide-a new chapter in rett syndrome's treatment.

PubMed lists PMID 38035006 in Frontiers in pharmacology as Journal Article, with publication-date metadata of 2023-11-16 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
December 2, 2023
Evidence lane
Literature metadata
Record added

Development of trofinetide for the treatment of Rett syndrome: from bench to bedside.

PubMed lists PMID 38318312 in Frontiers in pharmacology as Journal Article, with publication-date metadata of 2024-01-22 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 31, 2024
Evidence lane
Literature metadata
Record added

Managing Gastrointestinal Symptoms Resulting from Treatment with Trofinetide for Rett Syndrome: Caregiver and Nurse Perspectives.

PubMed lists PMID 38378975 in Advances in therapy as Clinical Trial, Phase III, Journal Article, with publication-date metadata of 2024-02-20 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
January 16, 2026
Evidence lane
Literature metadata
Record added

Look at DAYBUE™ (Trofinetide) as first ever drug for treatment of Rett Syndrome.

PubMed lists PMID 38555801 in Asian journal of psychiatry as Letter, with publication-date metadata of 2024-03-19 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 11, 2024
Evidence lane
Literature metadata
Record added

Recommendations for the management of gastrointestinal comorbidities with or without trofinetide use in Rett syndrome.

PubMed lists PMID 38869952 in Expert review of gastroenterology & hepatology as Journal Article, Review, with publication-date metadata of 2024-06-18 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 16, 2024
Evidence lane
Literature metadata
Record added

Trofinetide (Daybue) for Rett syndrome.

PubMed lists PMID 38981105 in The Medical letter on drugs and therapeutics as Journal Article, with publication-date metadata of 2024-07-08 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 15, 2024
Evidence lane
Literature metadata
Record added

Trofinetide treatment for Rett syndrome: Lessons to learn.

PubMed lists PMID 39395401 in Med (New York, N.Y.) as Journal Article, Comment, with publication-date metadata of 2024-10-11 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 4, 2026
Evidence lane
Literature metadata
Record added

Population Pharmacokinetics of Trofinetide in a Pediatric Population Aged 2-4 Years with Rett Syndrome.

PubMed lists PMID 39692837 in Advances in therapy as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-12-18 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 17, 2026
Evidence lane
Literature metadata
Record added

Assessing Experiences With Trofinetide for Rett Syndrome: Interviews With Caregivers of Participants in Clinical Trials.

PubMed lists PMID 39824747 in Clinical therapeutics as Journal Article, with publication-date metadata of 2025-01-16 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
May 22, 2025
Evidence lane
Literature metadata
Record added

Design, synthesis and evaluation of trofinetide prodrug based on diketopiperazine strategy.

PubMed lists PMID 41850142 in Bioorganic & medicinal chemistry as Journal Article, with publication-date metadata of 2026-03-14 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 11, 2026
Evidence lane
Literature metadata
Record added

Hydrophobic Tag-Assisted Scalable Synthesis of Trofinetide and Its GPE Analogues.

PubMed lists PMID 42083929 in Journal of peptide science : an official publication of the European Peptide Society as Journal Article, with publication-date metadata of 2026 (year precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
July 16, 2026
Evidence lane
Literature metadata
Record added

Rett syndrome and real-world treatment patterns of trofinetide in the United States.

PubMed lists PMID 42287113 in Journal of medical economics as Journal Article, with publication-date metadata of 2026-06-13 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
June 13, 2026
Evidence lane
Literature metadata
Record added

Real-World Treatment Landscape of Individuals with Rett Syndrome Treated and Untreated with Trofinetide in the United States.

PubMed lists PMID 42294489 in Journal of health economics and outcomes research as Journal Article, with publication-date metadata of 2026-06-11 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
September 26, 2026
Evidence lane
Literature metadata
Record added

Real-World Demographics, Clinical Characteristics, and Predictors of Persistence Among Males with Rett Syndrome Treated with Trofinetide.

PubMed lists PMID 42377739 in Advances in therapy as Journal Article, with publication-date metadata of 2026-06-30 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
October 1, 2026
Evidence lane
Literature metadata
Record added

Mapping Trofinetide Polypharmacology in Rett Syndrome: A Multi-Stage Computational Analysis.

PubMed lists PMID 42530159 in Journal of computational chemistry as Journal Article, with publication-date metadata of 2026-08-05 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Expert Consensus on Real-World Use of Trofinetide for Rett Syndrome Using a Modified Delphi Method.

PubMed lists PMID 42563928 in Annals of the Child Neurology Society as Journal Article, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 13, 2026
Evidence lane
Literature metadata
Record added

Characteristics of adult individuals with Rett syndrome treated or untreated with trofinetide in the United States.

PubMed lists PMID 42577214 in Frontiers in neurology as Journal Article, with publication-date metadata of 2026-07-27 (day precision). PeptideScanner associated the retained record with the identity slug trofinetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 15, 2026
Cited source date
August 28, 2026
Evidence lane
Literature metadata